Narrow Band Green Light and Migraine
A Real World Evaluation of the Allay Lamp in Reducing Headache Symptoms and Frequency
1 other identifier
interventional
182
1 country
1
Brief Summary
Study volunteers are asked to use the Allay Lamp routinely during the 6-week study period. A web based survey is provided when the Lamp is purchased for study volunteers to complete. A daily usage paper diary is sent with the lamp so that volunteers can keep track of the frequency and duration of lamp usage and any noticeable benefits. At the end of six weeks a second survey is sent to study volunteers to capture their perceptions of potential lamp benefits with respect to headache frequency and their experience of migraine specific symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2020
CompletedFirst Submitted
Initial submission to the registry
April 1, 2021
CompletedFirst Posted
Study publicly available on registry
April 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2022
CompletedDecember 8, 2022
December 1, 2022
1.5 years
April 1, 2021
December 6, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Change in number of headache days per week
Number of days with headache per week without and with using the Allay lamp
Change from baseline at 6 weeks
Change in number of headache days per month
Number of days with headache per month without and with using the Allay lamp
Changes from baseline at weeks 3-6 of using the Allay lamp
Change in frequency of experiencing photophobia
Assessing frequency of photophobia during days with headache as depicted by participants using the following options: (1)never, rarely, (2)less than half, (3)half or more, (4)nearly all the time.
Changes from baseline at 6 weeks of using the Allay Lamp.
Change in headache severity
Assessing headache severity while using the Allay lamp. Improvement is determined by the number of times participants answer Yes or NO in their daily diary.
Changes from baseline at 6 weeks of using the Allay lamp
Study Arms (1)
Allay lamp (narrow band green light)
EXPERIMENTALSubjects who purchased the Allay Lamp are asked to document the effects of spending time in the narrow band of green light it emits, on their headache or any of its associated symptoms.
Interventions
The Allay Lamp is a consumer product currently available and widely used in the US. It emits low intensity (1-10 lux) narrow band (20 nm) green light (peak wavelength 520 nm) that is marketed as non-irritating to users. In that context, it is not a medical device and does not require a 510(k).
Eligibility Criteria
You may qualify if:
- Adults with headaches or migraines.
You may not qualify if:
- Not having headaches or migraines
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vedanta Researchlead
Study Sites (1)
Vendata Research
Chapel Hill, North Carolina, 27517, United States
Related Publications (1)
Lipton RB, Melo-Carrillo A, Severs M, Reed M, Ashina S, Houle T, Burstein R. Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diary. Front Neurol. 2023 Oct 4;14:1282236. doi: 10.3389/fneur.2023.1282236. eCollection 2023.
PMID: 37859647DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Managing Director
Study Record Dates
First Submitted
April 1, 2021
First Posted
April 12, 2021
Study Start
December 15, 2020
Primary Completion
June 15, 2022
Study Completion
December 5, 2022
Last Updated
December 8, 2022
Record last verified: 2022-12